Citigroup Lowers Pulmonx (NASDAQ:LUNG) Price Target to $4.15
Pulmonx (NASDAQ:LUNG – Get Free Report) had its price objective lowered by equities researchers at Citigroup from $6.50 to $4.15 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price points to a potential upside of 33.44% from the stock’s current price. Other […]
Pulmonx (NASDAQ:LUNG – Get Free Report) had its price objective lowered by equities researchers at Citigroup from $6.50 to $4.15 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Citigroup’s target price points to a potential upside of 33.44% from the stock’s current price. Other […]
